Novartis AG
Compositions and methods for antibodies targeting complement protein C5
Last updated:
Abstract:
The present invention relates to antibodies targeting complement protein C5 and compositions and methods of use thereof.
Status:
Grant
Type:
Utility
Filling date:
17 Nov 2016
Issue date:
10 Sep 2019